| Azithromycin for prevention of exacerbations of COPD RK Albert, J Connett, WC Bailey, R Casaburi, JAD Cooper Jr, GJ Criner, ... New England Journal of Medicine 365 (8), 689-698, 2011 | 1581 | 2011 |
| The national lung screening trial: overview and study design National Lung Screening Trial Research Team Radiology 258 (1), 243-253, 2011 | 1362 | 2011 |
| Once-daily single-inhaler triple versus dual therapy in patients with COPD DA Lipson, F Barnhart, N Brealey, J Brooks, GJ Criner, NC Day, ... New England Journal of Medicine 378 (18), 1671-1680, 2018 | 1182 | 2018 |
| Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a … S Pascoe, N Locantore, MT Dransfield, NC Barnes, ID Pavord The lancet Respiratory medicine 3 (6), 435-442, 2015 | 851 | 2015 |
| Pulmonary arterial enlargement and acute exacerbations of COPD JM Wells, GR Washko, MLK Han, N Abbas, H Nath, AJ Mamary, E Regan, ... New England journal of medicine 367 (10), 913-921, 2012 | 557 | 2012 |
| Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised … MT Dransfield, J Bourbeau, PW Jones, NA Hanania, DA Mahler, J Vestbo, ... The Lancet Respiratory Medicine 1 (3), 210-223, 2013 | 403 | 2013 |
| Simvastatin for the prevention of exacerbations in moderate-to-severe COPD GJ Criner, JE Connett, SD Aaron, RK Albert, WC Bailey, R Casaburi, ... New England Journal of Medicine 370 (23), 2201-2210, 2014 | 393 | 2014 |
| Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung KR Genschmer, DW Russell, C Lal, T Szul, PE Bratcher, BD Noerager, ... Cell 176 (1), 113-126. e15, 2019 | 386 | 2019 |
| Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline GJ Criner, J Bourbeau, RL Diekemper, DR Ouellette, D Goodridge, ... Chest 147 (4), 894-942, 2015 | 371 | 2015 |
| Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease SP Bhatt, X Soler, X Wang, S Murray, AR Anzueto, TH Beaty, AM Boriek, ... American journal of respiratory and critical care medicine 194 (2), 178-184, 2016 | 370 | 2016 |
| A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE) GJ Criner, R Sue, S Wright, M Dransfield, H Rivas-Perez, T Wiese, ... American journal of respiratory and critical care medicine 198 (9), 1151-1164, 2018 | 369 | 2018 |
| Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission D Stolz, T Mkorombindo, DM Schumann, A Agusti, SY Ash, M Bafadhel, ... The Lancet 400 (10356), 921-972, 2022 | 340 | 2022 |
| GOLD 2011 disease severity classification in COPDGene: a prospective cohort study MLK Han, H Muellerova, D Curran-Everett, MT Dransfield, GR Washko, ... The lancet Respiratory medicine 1 (1), 43-50, 2013 | 339 | 2013 |
| Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease MT Dransfield, KM Kunisaki, MJ Strand, A Anzueto, SP Bhatt, RP Bowler, ... American journal of respiratory and critical care medicine 195 (3), 324-330, 2017 | 333 | 2017 |
| Chronic obstructive pulmonary disease and cardiovascular disease SP Bhatt, MT Dransfield Translational Research 162 (4), 237-251, 2013 | 323 | 2013 |
| Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial KM Kunisaki, MT Dransfield, JA Anderson, RD Brook, PMA Calverley, ... American journal of respiratory and critical care medicine 198 (1), 51-57, 2018 | 300 | 2018 |
| Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort MLK Han, PM Quibrera, EE Carretta, RG Barr, ER Bleecker, RP Bowler, ... The Lancet Respiratory Medicine 5 (8), 619-626, 2017 | 298 | 2017 |
| Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial FC Sciurba, GJ Criner, C Strange, PL Shah, G Michaud, TA Connolly, ... Jama 315 (20), 2178-2189, 2016 | 290 | 2016 |
| Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD MT Dransfield, SM Rowe, JE Johnson, WC Bailey, LB Gerald Thorax 63 (4), 301-305, 2008 | 285 | 2008 |
| Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort AT Hastie, FJ Martinez, JL Curtis, CM Doerschuk, NN Hansel, ... The Lancet Respiratory Medicine 5 (12), 956-967, 2017 | 277 | 2017 |
